Cardiovascular Diseases Research obligations in Massachusetts

Heart-research catalog meeting Massachusetts

CFDA 93.837 is titled CARDIOVASCULAR DISEASES RESEARCH. Crossed with Massachusetts place of performance, obligations sum to $2,663,736,229.35 on 1,093 awards. The national 93.837 hub includes every state. The Massachusetts spending hub includes every program. This tie is the overlap.

One thousand ninety-three awards is a dense investigator-grant pattern. Dollars sit in the billions because many instruments add up, not because each record is a statewide block. The join does not name hospitals, Boston versus Worcester labs, or trial protocols. Packet facts are $2,663,736,229.35, 1,093 awards, MA, and 93.837.

Readers sometimes treat a large CFDA–state total as if it were a budget line the state legislature passed. $2,663,736,229.35 is not that. It is the USAspending obligation sum on awards tagged 93.837 and MA. The overlay table at the program-in-state path is the same cell rendered as a page; this narrative is the join explained in prose. Nothing here ranks Massachusetts against other states on need, performance, or politics.

1093 awards totaling $2,663,736,229.35 (about $2.44 million mean) is cardiovascular research tagged MA. Heart-disease mortality is not a USAspending field. Aging research and CHIP are other Massachusetts cells and stay out of $2,663,736,229.35.

93.837 is not aging research and not CHIP

Aging research (a different CFDA) and Children's Health Insurance are separate Massachusetts joins. Mixing either into $2,663,736,229.35 would invent a broader total than this cell contains. Allergy and infectious-diseases research is another catalog.

Facts on this page: Massachusetts, CFDA 93.837, $2,663,736,229.35, 1,093 awards. Fiscal years, mechanism codes, and PI names are not in the facts. The title names the catalog, not Massachusetts mortality rates.

The only numeric facts on this packet are $2,663,736,229.35, 1093 awards, CFDA 93.837, program title Cardiovascular Diseases Research, and geography MA/Massachusetts. Any other dollar, year, recipient, or percentage would be invented. Trivial arithmetic from those facts is allowed: 1093 awards into $2,663,736,229.35 is about $2.44 million per award. That quotient is a mean of records, not a typical household, student, or lab.

NHLBI-style research is not a hospital-charge database. $2,663,736,229.35 on 1093 awards is 93.837 × MA. Clinical revenue and state public-health budgets are other systems.

Massachusetts as geography

MA is the place-of-performance code. Awards billed to Boston, Cambridge, or other in-state sites can share the tag. Awards coded to Rhode Island or New Hampshire stay outside $2,663,736,229.35 even when labs collaborate.

Massachusetts federal spending is the all-program parent. CFDA 93.837 is one row on the Massachusetts programs list. $2.66 billion is not the state’s complete federal footprint.

Place of performance MA is a two-letter code in the award file. It can mark a state capital, a campus, a housing authority, a transit agency, or a default statewide tag. It does not prove where every subcontract ran, and it does not convert $2,663,736,229.35 into a county map. Awards with a different state code are outside this cell even if people, patients, or riders cross the border.

Mean near $2.44 million

$2,663,736,229.35 ÷ 1,093 is about $2.44 million per award. That average is pulled by a large instrument count; it is not a median R01 and not a typical invoice. The aggregate reports net obligations. Without a transaction table, 1,093 is an award-record count, not 1,093 completed trials.

Treat 1093 as a record count in an aggregate, not as 1093 finished projects. USAspending obligations can be positive new awards or net of downward modifications; the $2,663,736,229.35 figure is the net total supplied in the facts. Without a transaction register on this page, you cannot see how many of the 1093 rows are continuations, renewals, or corrections.

Using the Cardiovascular Diseases Research–Massachusetts overlay

The overlay target for this tie is the Massachusetts × CFDA 93.837 table. Open that path when you want the same $2,663,736,229.35 / 1093-award cell in the site’s data chrome. The national program page for CFDA 93.837 drops the Massachusetts filter. The Massachusetts spending hub drops the CFDA filter. The Massachusetts programs index lists other catalogs beside Cardiovascular Diseases Research. All spending ties is the directory of other pairs.

This page exists because two tables meet: a CFDA program and a place-of-performance state. It does not exist to argue that Massachusetts “won” or “lost” federal money, that donations paid for the awards, or that obligations equal cash. Correlation is not causation. The headline number remains $2,663,736,229.35 on 1093 awards, from USAspending.gov, for Cardiovascular Diseases Research in Massachusetts.

What the pair cannot claim

A large 93.837 total in Massachusetts does not mean campaign donations funded the science. FEC and USAspending are different systems. Correlation is not causation. Outlays may differ from $2,663,736,229.35.

See Cardiovascular Diseases Research in Massachusetts, CFDA 93.837, Massachusetts federal spending, Massachusetts programs, and All spending ties.

Questions

How much cardiovascular research funding is obligated in Massachusetts?

USAspending records $2,663,736,229.35 in CFDA 93.837 obligations with Massachusetts place of performance across 1,093 awards. That is the pair aggregate, not all NIH spending in the state and not an outlay.

Does this include aging research?

No. Aging research uses a different CFDA number. This page is 93.837 only. The $2,663,736,229.35 total does not absorb those cells.

What is the average award size?

About $2.44 million ($2,663,736,229.35 ÷ 1,093). The mean is not a median and not a typical lab invoice.

Is this Massachusetts’s total federal spending?

No. The join filters CFDA 93.837 only. Other programs appear on the Massachusetts programs list and the statewide hub.